Benfotiamine

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

Benfotiamine, the lipid-soluble thiamine derivative used as a treatment for diabetic neuropathy.

Benfotiamine, the lipid-soluble thiamine derivative used as a treatment for diabetic neuropathy, can inhibit three major pathways(the hexosamine pathway, the advanced glycation end product (AGE) formation pathway and the diacylglycerol (DAG)protein kinase C (PKC) pathway）of hyperglycemic damage and prevent experimental diabetic retinopathy. Benfotiamine is a synthetic S-acyl derivative of thiamine (vitamin B1) for treating sciatica and other painful nerve conditions. More effective at increasing thiamin levels in blood and tissues than water-soluble salts like the previous vitamin B1.

Benzoylthiamine monophosphate

Others

Other Targets

Others

Neurological Disease

——

22457-89-2

466.46

C19H23N4O6PS

>98%(HPLC)

Soluble in DMSO

O=C(S/C(CCOP(O)(O)=O)=C(N(CC1=CN=C(C)N=C1N)C=O)/C)C2=CC=CC=C2

(Z)-S-(2-(N-((4-amino-2-methylpyrimidin-5-yl)methyl)formamido)-5-(phosphonooxy)pent-2-en-3-yl) benzothioate

(-20℃)

With Ice Pack

≥ 2 years